Mc Coy Drugs Private Limited, a active private limited company, was established on 04 June 2004 in Surat, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230GJ2004PTC098840. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.84 Cr.
It upholds a compliant status. Its leadership includes Rinamkumar Nalinkumar Shah (Director), Nihar Shah (Director), Suken Dineshchandra Shah (Director). Past directors included Ketankumar Navinchandra Shah, Bhavesh Gunvantlal Shah, Priti Arun Joshi. It holds ₹4.75 Cr open charges and ₹4.70 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.146-147, Sez Sachin,, Surat, Gujarat, 394320.
U24230GJ2004PTC098840
098840
04 June 2004
₹5.00 Cr
₹4.84 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Mc Coy Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rinamkumar Nalinkumar Shah | Director | 01 Jul 2004 | Current |
| Nihar Shah | Director | 30 Dec 2022 | Current |
| Suken Dineshchandra Shah | Director | 10 Feb 2016 | Current |
| Mehul Satish Choksi | Director | 10 Feb 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Mar 2022 | Past |
| Pramod Abcsdd | Director | 13 Mar 2019 | Past |
| Pramod Abcsdd | Additional Director | 15 May 2009 | Past |
| Pramod Abcsdd | Director | 02 Mar 2023 | Past |
| Pramod Abcsdd | Director | 22 Aug 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mc Coy Drugs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 32.07% decrease. The company also saw a substantial improvement in profitability, with a 863.35% increase in profit. The company's net worth moved up by a moderate rise of 0.28%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Mc Coy Drugs had a promoter holding of 93.81% and a public holding of 6.19%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹47,500,000.00
₹47,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jul 2020 | Others | ₹2.50 M | Open |
| 18 Jul 2018 | Tata Capital Financial Services Limited | ₹1.50 Cr | Open |
| 04 Sep 2017 | Others | ₹3.00 Cr | Open |
| 05 Oct 2009 | The Cosmos Co-Operative Bank Ltd. | ₹1.90 Cr | Satisfied |
| 05 Oct 2009 | The Cosmos Co-Operative Bank Limited | ₹2.80 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Mc Coy Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mc Coy Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mc Coy Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Mc Coy Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Mc Coy Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
The activity Nihar Shah was appointed as a Director was appointed as a Director on 30 Dec 2022 & has been associated with this company since 2 years 10 months . was completed.
A charge registered on 05 Oct 2009 via Charge ID 10184112 with The Cosmos Co-Operative Bank Ltd. was fully satisfied on 14 Jul 2022. was recorded as a recent event.
Progress on A charge registered on 05 Oct 2009 via Charge ID 10184116 with The Cosmos Co-Operative Bank Limited was fully satisfied on 14 Jul 2022. was documented.
Progress on A charge with Others amounted to Rs. 0.25 Cr with Charge ID 100356026 was registered on 27 Jul 2020. was documented.
The CIN of Mc Coy Drugs Private Limited is U24230GJ2004PTC098840.
Mc Coy Drugs Private Limited is headquartered at Plot No.146-147, Sez Sachin,, Surat, Gujarat, 394320.
Mc Coy Drugs Private Limited was incorporated on 04 June 2004.
The current directors of Mc Coy Drugs Private Limited are
The primary industry of Mc Coy Drugs Private Limited is Manufacturing.
Mc Coy Drugs Private Limited is unlisted.
The authorized capital of Mc Coy Drugs Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.84 Cr.
The compliance status of Mc Coy Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX